The purpose of this study is to evaluate the safety and tolerability (able to bear) of the study drug and also to understand the extent of this study drug’s absorption, levels of study drug in your blood and effects of the study drug.
In general good health
Not having used tobacco products or nicotine-containing products within 30 days prior to dosing
Not have a history of pituitary and/or adrenal gland diseases
Have a BMI (Body Mass Index) between 18 kg/m2 to 30 kg/m2 inclusive and weigh at least 50kg
Other criteria will be assessed
This study has been approved by Advarra Ethics Board
Weekdays, Weekends, Overnight, Weeknights
6 days total, 4 sessions
The study will be approximately 34 days in total, including screening, Period 1, and Period 2. For both Period 1 and Period 2, you will be required to stay at the Cliantha Research facility for two overnight stays. There is a 10-day washout in between the two periods. After Period 2, one end-of study follow-up visit is required.
Up to $2550
4500 Dixie Rd Mississauga, Ontario, Canada, L4W 1N2